Compare Goodyear Tire & Rubber Co (GT) vs Natera Inc. Common Stock (NTRA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Goodyear Tire & Rubber Co vs Natera Inc. Common Stock — how do they compare? Goodyear Tire & Rubber Co trades at $4.42 (market cap $1.26B), while Natera Inc. Common Stock trades at $392.78 (market cap $57.03B). The key difference: Natera Inc. Common Stock is far larger — about 45.3× Goodyear Tire & Rubber Co's market cap, and Natera Inc. Common Stock is trading nearer its 52-week high, Goodyear Tire & Rubber Co nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Goodyear Tire & Rubber Co for 58 Days and Natera Inc. Common Stock for 0 Days on average.
| GT | NTRA | |
|---|---|---|
Market Cap | $1.26B | $57.03B |
Volume | 7,768,478 | 1,131,157 |
Sector | Consumer Cyclical | Health |
52-Week High | $10.54 | $425.64 |
52-Week Low | $4.38 | $179.42 |
Typical Hold Time | 58 Days | 0 Days |
Enterprise Value | $8.61B | $56.18B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
GT trades at $4.56, up 1.56% on the day, but remains in a bearish technical trend with the stock near its 52-week low. The company reported a net loss of $1.72 billion in 2025, with negative profit margins and ROE, though it beat Q1 and Q2 2026 EPS estimates. Cash flow from operations improved to $796 million in 2025, but high debt levels and restructuring efforts under a new strategy are key focal points.
The outlook is challenged by persistent losses and volume pressure, but analyst consensus suggests upside with a $8.00 price target. Investment opportunity hinges on successful execution of the margin-focused turnaround; key risks include execution missteps, competitive pressures, and macroeconomic headwinds affecting tire demand.
NTRA trades at $395.66, down 0.53% today but remains near recent highs. The stock shows mixed technical signals with neutral momentum indicators. Fundamentally, the company demonstrates strong revenue growth ($2.31B in 2025, projected $2.7B in 2026) but continues to operate at a net loss (-$208M in 2025). Recent positive developments include FDA Breakthrough Device designation for its multi-cancer detection assay and regulatory approval in Japan for Signatera.
NTRA presents a growth story with significant analyst support (89% buy ratings) but carries execution risks. The stock trades at premium valuations (P/S 20.48) while still unprofitable. Key catalysts include clinical trial progress and international expansion, though investors face risks from ongoing losses and competitive pressures in precision medicine.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Goodyear Tire & Rubber Co
Goodyear Tire & Rubber Co manufactures and sells a variety of rubber tires under the Goodyear brand name. The firm's tires are used for automobiles, trucks, buses, aircraft, motorcycles, mining equipment, farm equipment, and industrial equipment.
Read more on GT →About Natera Inc. Common Stock
Natera, Inc. develops and provides cell-free DNA-based genetic testing across women's health, oncology, organ health, and rare disease, with flagship products including Panorama for noninvasive prenatal screening and Signatera for cancer recurrence monitoring.
Read more on NTRA →
